IVF Devices and Consumables

Global IVF Devices and Consumables Market to Reach US$5.2 Billion by 2030

The global market for IVF Devices and Consumables estimated at US$4.2 Billion in the year 2024, is expected to reach US$5.2 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Culture Media & Reagents, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.5 Billion by the end of the analysis period. Growth in the Accessories & Disposables segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 7.2% CAGR

The IVF Devices and Consumables market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global IVF Devices and Consumables Market – Key Trends & Drivers Summarized

Why Are IVF Devices and Consumables Gaining Prominence in Reproductive Healthcare?

In vitro fertilization (IVF) devices and consumables have become a cornerstone of modern reproductive healthcare, offering hope to millions of couples worldwide facing infertility challenges. The rise in infertility rates, driven by factors such as delayed childbearing, lifestyle changes, environmental pollutants, and certain medical conditions, has increased the demand for assisted reproductive technologies. IVF, in particular, has become a widely accepted and accessible procedure, supported by both public and private healthcare institutions. The market encompasses a broad range of equipment and materials, including embryo culture dishes, incubators, micro-manipulation tools, cryopreservation systems, and media for fertilization and embryo transfer. The success of IVF treatments depends significantly on the precision and quality of these devices and consumables, as they facilitate the delicate processes of gamete manipulation, embryo development, and transfer. Increased awareness about fertility treatments, growing acceptance of single-parent and LGBTQ+ families seeking biological children, and the expansion of fertility clinics in both developed and emerging markets have fueled consistent market growth. Additionally, many nations are now offering financial support or insurance coverage for IVF treatments, reducing the financial barrier and encouraging more individuals to pursue reproductive assistance. As societal norms evolve and infertility becomes more openly discussed, the demand for advanced, reliable, and safe IVF products continues to rise, underscoring the market’s critical role in shaping future demographics and reproductive autonomy.

How Are Technological Advancements Enhancing IVF Success Rates and Market Demand?

Technological innovation is playing a pivotal role in improving IVF outcomes and expanding the market for IVF devices and consumables. Cutting-edge advancements such as time-lapse embryo imaging, AI-powered embryo selection, and high-resolution imaging techniques have enhanced the ability of clinicians to identify viable embryos, leading to higher success rates and fewer cycles needed per patient. Automation in laboratory equipment, including advanced incubators and micromanipulators, has also improved consistency and minimized human error. Cryopreservation techniques, particularly vitrification, have significantly improved survival rates of oocytes and embryos during storage, expanding options for delayed pregnancies and fertility preservation. Robotic systems and automated sperm analyzers are streamlining lab workflows, reducing variability and increasing throughput. Additionally, innovations in culture media composition and pH regulation technologies have optimized the embryonic environment, improving developmental outcomes. Consumables like sterile labware, single-use catheters, and embryo handling tools are increasingly being designed for greater precision, traceability, and contamination prevention. Cloud-based platforms for data tracking and patient management are enhancing transparency and customization of treatment protocols. These advancements have made IVF not only more effective but also safer and more accessible, attracting a broader patient base. Clinics are now able to offer personalized fertility treatments, catering to complex cases involving genetic screening, recurrent implantation failure, or age-related fertility decline. As technologies continue to evolve, the adoption of next-generation IVF devices and consumables is expected to accelerate, positioning the market for robust and sustained growth across both clinical and consumer-facing fertility care segments.

How Do Regional and Demographic Trends Shape the Demand for IVF Devices and Consumables?

Regional disparities in fertility rates, healthcare infrastructure, cultural attitudes, and regulatory policies significantly influence the demand for IVF devices and consumables across global markets. In high-income regions such as North America and Western Europe, rising maternal age, dual-career households, and access to advanced medical care have fueled demand for assisted reproductive technologies. Countries like the United States, Germany, and the United Kingdom have well-established fertility industries supported by robust insurance frameworks and widespread availability of cutting-edge IVF technologies. In Asia-Pacific, rapid urbanization, increasing infertility rates, and expanding middle-class populations are driving a surge in fertility clinic development and treatment uptake, particularly in countries like India, China, Japan, and South Korea. Government initiatives to counter declining birth rates and favorable reimbursement policies are supporting this growth. Meanwhile, in the Middle East and parts of Africa, cultural openness toward fertility interventions is growing, albeit at varying paces depending on religious and social contexts. These regions are beginning to invest in fertility infrastructure and trained professionals, which will eventually lead to increased demand for high-quality devices and consumables. Latin America is witnessing gradual growth fueled by private clinics and medical tourism. Across all regions, there is a marked increase in the number of fertility centers, embryologists, and gynecologists specializing in reproductive medicine. Moreover, younger generations are showing greater openness to fertility preservation through egg and sperm freezing, expanding the consumables market for cryogenic and storage solutions. As global awareness increases and barriers to care diminish, demographic and regional trends will continue to shape a diverse, geographically expansive IVF market ecosystem.

What Factors Are Driving the Continued Growth of the IVF Devices and Consumables Market?

The growth in the IVF devices and consumables market is driven by several interconnected factors tied to demographic shifts, medical advancements, policy developments, and consumer behavior. One of the most powerful drivers is the global rise in infertility, spurred by changing lifestyles, increasing stress levels, late marriages, and conditions such as polycystic ovarian syndrome and endometriosis. Growing awareness and acceptance of assisted reproductive technologies have led to greater patient volumes at fertility clinics, both in urban centers and increasingly in secondary cities. The trend toward delayed parenthood, particularly among professional women, has led to an upsurge in demand for egg freezing and fertility preservation, bolstering the need for cryopreservation devices and media. Public and private healthcare entities are increasingly offering subsidies or mandating insurance coverage for IVF treatments, expanding access across socioeconomic strata. Technological improvements in lab automation, embryo selection, and gamete storage have enhanced success rates, making IVF a more attractive and viable option. Furthermore, the entry of private equity and healthcare investors into the fertility sector has fueled the establishment and expansion of fertility centers globally, increasing the market’s absorptive capacity for devices and consumables. Cross-border reproductive care and fertility tourism have also added new customer segments, particularly in regions offering cost-effective, high-quality IVF services. Digital marketing and social media campaigns by clinics and fertility influencers are reshaping patient education and driving demand. As consumer expectations rise and fertility becomes a longer-term health consideration, the demand for reliable, effective, and technologically sophisticated IVF devices and consumables is set to remain on an upward trajectory globally.

SCOPE OF STUDY:

The report analyzes the IVF Devices and Consumables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Culture Media & Reagents, Accessories & Disposables, Instruments)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Cook Medical
• CooperSurgical
• Cryo Bio System
• Esco Medical
• Fertility Technology Solutions
• FUJIFILM Irvine Scientific
• Genea Biomedx
• Hamilton Thorne
• IVFtech
• Kitazato Corporation
• Labotect GmbH
• Merck KGaA
• Nidacon International
• Origio (part of CooperSurgical)
• Progyny
• Rocket Medical
• Smiths Medical
• The Baker Company
• Thermo Fisher Scientific
• Vitrolife

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.